We hypothesized that the combination of TyG, a reliable IR surrogate marker, and ALT, which reflects hepatic inflammation and injury, would increase both sensitivity and specificity for the evaluation of NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.